Fenwal Inc. has been acquired by a public company.
PrivCo has ceased its coverage of Fenwal Inc. and below is the archived report.
Fenwal is a privately held healthcare company that develops and manufactures services for the transfusion industry. Fenwal's products include: InterSol, an additive solution to replace a portion of plasma used when storing platelets for up to five days; InterSol, an additive solution to replace a portion of plasma used when storing platelets for up to five days; and Fenwal DXT Relay productivity software. Fenwal was founded in 2006 and has headquarters in Lake Zurich, IL.
Overview & Corporate Organization
PrivCo Industries (Sector > Industry > Sub-Industry)
|Healthcare > Medical Devices & Equipment > Medical Device & Equipment Manufacturing|
|Healthcare > Medical Devices & Equipment > Medical Device Design & Manufacturing|
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Mergers & Acquisitions
Missing a deal? Tell us about it! email@example.com